Delayed response to 2-deoxy-D-glucose in hypothalamic obese rats

Area of Science:

• Neuroscience
• Endocrinology
• Behavioral Science

Background:

• The ventromedial hypothalamus (VMH) plays a critical role in regulating energy balance and feeding behavior.
• Glucoreceptors in peripheral tissues signal glucose levels to the brain, influencing appetite.
• 2-deoxy-D-glucose (2-DG) is a glucose analog used to probe central glucoregulatory mechanisms.

Purpose of the Study:

• To establish a dose-response relationship for 2-deoxy-D-glucose (2-DG)-induced food intake in normal and obese rats with VMH lesions.
• To investigate the impact of VMH lesions on the effects of 2-DG on feeding behavior.

Main Methods:

• Rats, both normal and with VMH lesions (obese), were administered varying doses of 2-DG (0-400 mg/kg).
• Food intake was measured over a 4-hour period following 2-DG injection.
• Latency to the first feeding bout and the magnitude of food intake were analyzed.

Main Results:

• In normal rats, 2-DG significantly increased food intake starting at 100 mg/kg, with dose-dependent augmentation.
• Obese VMH-lesioned rats exhibited delayed increases in food intake at doses of 150-400 mg/kg 2-DG.
• Higher doses of 2-DG (300-400 mg/kg) inhibited food intake in obese rats during the first hour post-injection.

Conclusions:

• VMH lesions alter the sensitivity and temporal dynamics of 2-DG-induced feeding.
• The findings suggest that VMH lesions disrupt the processing of signals from peripheral glucoreceptors, affecting 2-DG's satiating or appetite-stimulating effects.
• These results contribute to understanding the neurobiological basis of obesity and appetite regulation.